Financial Times ft.com 2026-06-27 10:00

QuidelOrtho looks to sell testing unit as PE circles healthcare companies

Diagnostic company’s shares are down 90% since its rapid antigen tests were the first to be approved for Covid-19

Read full article at Financial Times ↗

This summary is provided by Daily Junction. The original article is published by Financial Times and all rights remain with the original publisher.

Related coverage on Daily Junction

Daily Briefing

The day's biggest stories in one free email. Join 12,616 readers.